找到正确的研究设计。
Ensure your study demonstrates your product's value and drives better patient outcomes. We will help you design the right study for your needs.
Smarter ways to generate evidence
开发治疗的成本增加需要更明智的方法。从现有的二级数据，主要数据，注册表协作以及患者报告的结果中访问广泛的数据和采购方法。
每项研究都是不同的。点击我们的合适研究设计。IQVI手机版必威A核心支持基于我们的领域专业知识，无与伦比的数据，变革性技术和高级分析的特定研究需求。
IQVIA is the perceived RWE market thought leader and expert across RWD sources and proper use, RWD analytical capabilities and RWE generation – by a significant margin.Source - Life Science Strategy Group, LLC – Real World Evidence Report
Smarter study approaches
We are reimagining evidence generation with innovative approaches you can leverage right now, today.
- Enriched Study Methodology:将来自非识别数据库（例如EMR，索赔，研究队列）的次要数据与医生和患者的主要数据集成在一起，以建立特定于您的研究的全面患者记录。Learn more here.
- External Comparator Studies:使用现实世界数据，提高操作效率并自信地回答监管机构和付款人的要求，为单臂试验提供背景。
- Extension Studies:Meet additional research objectives by keeping patients and investigators engaged post-trial. Drive efficiencies and capture long-term patient outcomes to understand the long-term safety and effectiveness of your drug.
- 务实的试验：Generate Real World Evidence to evaluate the effectiveness of a randomized intervention in real-life conditions, helping you answer Regulators’ and Payers questions on your product.
Accelerated recruitment
By connecting with existing real world data sources, we can more easily find the right patients and quickly move to recruitment.
Regulatory knowledge
当前的工作知识有助于确保您的研究符合监管标准。作为OMOP，Encepp，Eunethta，IMI，卫生与公共服务部等其他的活跃合作伙伴和参与者，IQVIA致力于为客户的利益而保持最新状态。必威手机APP
Learn how to develop a framework to qualify RWE in the context of a particular study.
Richer real world data insights can drive smarter decisions.
Automate and customize data analysis and get the most out of your portfolio with scalable platforms.